Clinical trial Recruiting at 1 site Observational Ages 18 to 90

Measuring oxygen levels in the heart during open-heart surgery

Official title: Spectroscopic Assessment of Intramyocardial Oxygen Saturation During Open-Heart Surgery

Run by Spectrocor · NCT06084091 · Data updated 2026-11-12

This study is testing a new device that measures oxygen levels in the heart during open-heart surgery to see how it affects recovery and heart function afterward.

More Coronary Artery Disease trials

Quick facts

Study typeObservational
Ages18 Years to 90 Years
SexAll
Enrollment40 (estimated)
SponsorSpectrocor
Industry-sponsored
Locations1 site (Helsinki, Uusimaa)
StatusRecruiting
StartedOctober 6, 2023
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedAugust 21, 2026
Trial IDNCT06084091 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients aged 18 to 90 scheduled for open-heart surgery who can provide informed consent.

Probably not a fit

Patients who are unable to provide informed consent or belong to vulnerable populations may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the safety and performance of a device that measures myocardial oxygen saturation during open-heart surgery. It will record spectrometric data to analyze how these measurements correlate with clinical events and parameters during the procedure. The study will monitor the depth of ischemia and its relationship to postoperative heart function and morbidity. A qualified monitor will oversee the trial to ensure compliance with Good Clinical Practice and quality standards.

Why it matters

Potential benefit: If successful, this study could improve intraoperative monitoring and outcomes for patients undergoing open-heart surgery.

How similar studies have gone: While this approach is innovative, similar studies have shown promise in improving intraoperative monitoring techniques.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Any 18 to 90-year-old patient scheduled for an open-heart operation
* The ability to understand the study's objective and the risks involved.
* Informed consent obtained, including the agreement to authorization to use the protected personal patient records according to privacy legislation.

Exclusion Criteria:

* Inability to obtain an informed consent form
* Patients included as vulnerable population according to Finnish Medical Research Act, including retarded, pregnant women, nursing mothers, prisoners, or forensic patients.

Where it's running

  • Heart and Lung Center
    Helsinki, Uusimaa, Finland
    Recruiting

Study contacts

  • Principal investigator: Peter Raivio, PhD — Chief of Department, Head and Lung Center, Hospital District of Helsinki and Uusimaa
  • Study coordinator: Peter Raivio, PhD
  • Email: peter.raivio@hus.fi
  • Phone: +358 50 4272283

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.